BioMarin Pharmaceutical (BMRN) total liabilities

Total liabilities · fiscal 2025
$1.51B

BioMarin Pharmaceutical (BMRN) had total liabilities of $1.51B at the end of fiscal 2025 (December 31, 2025). That is 13.2% higher than the $1.33B of fiscal 2024. Figures as of 18 Nov 2026, 23:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$1.51B
Change on fiscal 2024
+13.2%
Growth, 5 years
−2.9% a year
Growth, 10 years
+1.3% a year
Highest on record
$1.89Bfiscal 2023
Lowest on record
$532.66Mfiscal 2011
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

BioMarin Pharmaceutical total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities shrank at a compound 2.9% a year; over ten years the rate was 1.3% a year. Across the 17 fiscal years on record (2009–2025), the highest was $1.89B in fiscal 2023 and the lowest $532.66M in fiscal 2011.

History · 17 fiscal years

Total liabilities by fiscal year

BioMarin Pharmaceutical total liabilities, year by year

BioMarin Pharmaceutical (BMRN) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$1.51B 13.2% up
2024$1.33B 29.6% down
2023$1.89B 6.7% up
2022$1.77B 1.9% up
2021$1.74B 0.2% down
2020$1.74B 11.1% up
2019$1.57B 7.4% up
2018$1.46B 20.0% down
2017$1.82B 45.1% up
2016$1.26B 5.4% down
2015$1.33B 40.2% up
2014$947.49M 4.9% up
2013$903.02M 63.4% up
2012$552.58M 3.7% up
2011$532.66M 2.3% down
2010$545.37M 8.3% down
2009$594.98M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of BioMarin Pharmaceutical and comparable companies
CompanyTotal liabilitiesFiscal year
Universal Health Services UHS$8.12B2025
Repligen RGEN$843.57M2025
Bio-Techne TECH$478.51M2026
BioMarin Pharmaceutical BMRN$1.51B2025
Avantor AVTR$6.23B2025
Ensign Group ENSG$3.23B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BMRN

BioMarin Pharmaceutical, figure by figure

BioMarin Pharmaceutical (BMRN) overview: price, valuation and scorecardAll health care companies by market value

BioMarin Pharmaceutical total liabilities: questions and answers

How large are BioMarin Pharmaceutical's total liabilities?

BioMarin Pharmaceutical (BMRN) had total liabilities of $1.51B at the end of fiscal 2025 (December 31, 2025). That is 13.2% higher than the $1.33B of fiscal 2024.

What is the growth rate of BioMarin Pharmaceutical's total liabilities?

Over the five fiscal years to 2025 total liabilities shrank at a compound 2.9% a year; over ten years the rate was 1.3% a year.

What are the highest and lowest total liabilities figures on record for BioMarin Pharmaceutical?

Across the 17 fiscal years on record (2009–2025), the highest was $1.89B in fiscal 2023 and the lowest $532.66M in fiscal 2011.

How is BioMarin Pharmaceutical's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For BioMarin Pharmaceutical it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BioMarin Pharmaceutical (BMRN) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/BMRN/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.